Spruce Biosciences (SPRB) Earnings Date & Reports

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders withÂ unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRB is expected to report earnings to fall 70.18% to -17 cents per share on May 07

Spruce Biosciences SPRB Stock Earnings Reports

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.36

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.10

Q1'24

Beat

by $0.08

The last earnings report on March 12 showed earnings per share of -56 cents, missing the estimate of -20 cents. With 813.48K shares outstanding, the current market capitalization sits at 5.60M.

View a ticker or compare two or three

Compare

SPRB